Skip to content
  • About
  • Contact
  • Our Staff
  • Advertise
US Pharma Marketing Logo

US Pharma Marketing

  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A

Industry Landscape

Articles under this category focus on macro trends, big pharma behavior, and annual outlooks.

Veeva-Salesforce Divorce Finalized: What It Means for Pharma Marketers in 2025
Posted in
  • Industry Landscape

Veeva-Salesforce Divorce Finalized: What It Means for Pharma Marketers in 2025

When industry alliances collapse, the tremors often extend far beyond the boardroom. The Veeva-Salesforce split, finalized … Veeva-Salesforce Divorce Finalized: What It Means for Pharma Marketers in 2025Read more

by Gurinder Khera•May 14, 2025May 14, 2025•0
The Impact of Telehealth Growth on Pharma Marketing Strategies
Posted in
  • Industry Landscape

The Impact of Telehealth Growth on Pharma Marketing Strategies

Telehealth was never meant to be a disruptor. But it became one. When the COVID-19 pandemic … The Impact of Telehealth Growth on Pharma Marketing StrategiesRead more

by Gurinder Khera•May 14, 2025May 14, 2025•0
How Big Pharma Spends Its Marketing Dollars
Posted in
  • Industry Landscape

How Big Pharma Spends Its Marketing Dollars

Step into a world where billions of dollars don’t chase cures but craft narratives, sway doctors, … How Big Pharma Spends Its Marketing DollarsRead more

by Gurinder Khera•May 9, 2025May 9, 2025•0
The State of Pharma Marketing in the U.S. (2025 Outlook)
Posted in
  • Industry Landscape

The State of Pharma Marketing in the U.S. (2025 Outlook)

Picture a patient scrolling through their phone, bombarded by ads for medications they’ve never heard of, … The State of Pharma Marketing in the U.S. (2025 Outlook)Read more

by Gurinder Khera•May 9, 2025May 9, 2025•0

Posts pagination

Previous 1 … 5 6

Recent Posts

  • Biopharma Layoffs: Optimizing Sales Teams Amid Workforce Shifts
  • Competitive Intelligence Surge: Elevating Pharma Marketing Insights
  • Eli Lilly Trades AI Access for Biotech Data to Drive Precision Marketing in Obesity and Alzheimer’s
  • FDA’s Crackdown on Pharma’s Digital Marketing: What the Warning Letters to Lilly, Novo, and Novartis Signal for the Future of DTC Advertising
  • Top-Selling Biotech Drugs & Revenue Forecasts: Tracking Blockbusters and the Road Ahead

Recent Comments

No comments to show.
Copyright © 2025 US Pharma Marketing.
Powered by WordPress and HybridMag.
  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A